Crescent Biomedical

Crescent Biomedical was founded in 2005 to provide due diligence services to med-tech investors and a broad array of services to both med-tech and high-tech companies that enable technology development partnerships and product commercialization. These services are provided through an alliance of independent consultants who have a proven track record in the industry and their profiles span a broad range of technologies and markets that include home health and critical care monitors, physician office and point of care diagnostics, drug delivery devices and insulin pumps, heart assist and endovascular devices, telecare and breath analysis devices. We have successfully supported both public and private corporations of various sizes by providing timely and cost effective services, and served as advisors to venture partners and board members. Our services provide tangible value in: Taking innovation into production, predictably and repeatably, Finding the right fit begins with the right criteria, Removing regulatory uncertainty from product development, Turning market needs into market share, Making sure that the whole is greater than the sum of its parts, Balancing the need to proceed with the need to evaluate.